Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...

“Most people with asthma have one or more preventer inhalers (which control your asthma) and a reliever or rescue inhaler (usually blue), which relieves symptoms,” the patient advice brochure ...

“Most people with asthma have one or more preventer inhalers (which control your asthma) and a reliever or rescue inhaler (usually blue), which relieves symptoms,” the patient advice brochure ...

for patients with asthma and chronic obstructive pulmonary disease (COPD). Teva noted it is the first and only digital rescue inhaler indicated in patients four years or older for the treatment ...

It was the first anti-inflammatory-based rescue ... inhalers from other manufacturers, including GSK, Boehringer Ingelheim, and Teva, and Adherium also sells the device directly to patients with ...

Systemic corticosteroids (CS) should be considered as first-line treatment for acute asthma exacerbations ... a proposal for the use of inhaled CS as a rescue medication in the emergency ...

The news followed an investigation by POLITICO’s E&E News into climate-friendly inhalers and how drug giants are developing them to undermine competition. The pharmaceutical giant AstraZeneca ...